In the BioHarmony Drug Report Database

"Preview" Icon

Enfuvirtide

Fuzeon (enfuvirtide) is a protein pharmaceutical. Enfuvirtide was first approved as Fuzeon on 2003-03-13. It is used to treat acquired immunodeficiency syndrome and HIV infections in the USA. It has been approved in Europe to treat HIV infections.

 

Trade Name

 

Fuzeon
 

Common Name

 

enfuvirtide
 

ChEMBL ID

 

CHEMBL525076
 

Indication

 

acquired immunodeficiency syndrome, hiv infections
 

Drug Class

 

Peptides: antiviral peptides; antivirals

Image (chem structure or protein)

Enfuvirtide structure rendering